DSM-Firmenich has broken ground on a new production facility in Parma, Italy, aimed at expanding its Located in Parma’s 'Food Valley', the new site will be situated near Campus Italy, DSM-Firmenich’s centre Maurizio Clementi, EVP of Taste at DSM-Firmenich, said: “Our investment in another facility in Parma, Albert Plans, senior VP of operations, Taste at DSM-Firmenich, added: “Our decision to build in Parma

DSM-Firmenich and Meiji Holdings have signed an MoU to enhance the sustainability of Japanese dairy farming Mark van Nieuwland, VP of Bovaer at DSM-Firmenich, said: “We are excited to expand the use of Bovaer You might also be interested in: DSM-Firmenich and Deloitte partner on animal protein sustainability DSM-Firmenich to separate Animal Nutrition & Health business Meiji to build new JPY 48bn dairy plant

DSM-Firmenich has opened a new US baking innovation facility in Princeton, New Jersey, as part of a broader manufacturers and brand owners will benefit from access to tasting panels, concept screening technologies and DSM-Firmenich DSM-Firmenich said the facility will allow for faster, more integrated product development and minimise Chris Perkins, senior vice president for Taste, Texture and Health, North America at DSM-Firmenich, said

DSM-Firmenich has inaugurated its new Van Marken Food Innovation Center in Delft, the Netherlands, marking The new site will serve as the headquarters of DSM-Firmenich’s Taste, Texture and Health business unit after Jacques van Marken, founder of the Yeast and Spirits Factory – later Gist-Brocades, acquired by DSM DSM-Firmenich and its predecessors have operated in Delft since 1869, contributing food innovations such

DSM-Firmenich has completed the sale of its yeast extract business to Lesaffre, a French company specialising The deal, initially announced in June , will see 46 DSM-Firmenich employees transfer to Lesaffre. As part of the transaction, Lesaffre will supply yeast extracts to DSM-Firmenich for its Savory business

DSM-Firmenich Animal Nutrition & Health has formed a partnership with Zenkei Company, a livestock nutrition The two companies have signed a Memorandum of Understanding to implement DSM-Firmenich’s Sustell, a life The partnership will see Zenkei implement DSM-Firmenich’s cloud-based solution to measure, optimise, Mongkol Kaewsutas, director of precision services for Greater APAC at DSM-Firmenich Animal Nutrition

DSM-Firmenich has launched four new rotations of its Dairy Safe cultures, designed specifically for the DSM-Firmenich's new Dairy Safe cultures are positioned to meet these demands by providing effective bioprotection Pim van Hee, global business director for cheese cultures at DSM-Firmenich, said: “Spoilage can be devastating Evandro Oliveira de Souza, global senior vice president at DSM-Firmenich, noted: “With Dairy Safe, we

DSM-Firmenich has unveiled MaxirenEVO, a novel coagulant enzyme aimed at enhancing the cheese production Ardy van Erp, business director for cheese at DSM-Firmenich, noted the importance of this innovation

DSM-Firmenich has unveiled Maxilact Next, which the company says is “the fastest pure lactase available Rodolfo Garza, global business development manager of milk and plant-based alternatives at DSM-Firmenich DSM-Firmenich says that 70% of consumers worldwide are unable to properly digest lactose and that its

Plant-based start-up Meala FoodTech has partnered with DSM-Firmenich to launch Vertis PB Pea, a texturizing Through Meala’s partnership with DSM-Firmenich, the solution is now available to customers in Europe. Razmovich, CEO and co-founder of Meala FoodTech, commented: “We’re looking forward to working with DSM-Firmenich

The recipe for success DSM-Firmenich has the ingredients, technology and formulation expertise to help this conversation will be Francesc Puerto, technical sales manager in Europe for sugar reduction, at DSM-Firmenich

DSM-Firmenich has announced the completion of the sale of its 100% equity interest in DSM Jiangshan Pharmaceutical In June 2023, DSM-Firmenich announced a restructuring of its vitamin assets aimed at significant cost